Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 4
262
Views
20
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro

, , , , , , & show all
Pages 297-303 | Received 30 Mar 2016, Accepted 19 May 2016, Published online: 16 Jun 2016

References

  • Brown CM, Reisfeld B, Mayeno AN. (2008). Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev 40:1–100.
  • Chan TY. (2001). Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 35:501–4.
  • Chen XM, Wei M, Zhang HM, et al. (2012). Effect of vanillin and ethyl vanillin on cytochrome P450 activity in vitro and in vivo. Food Chem Toxicol 50:1897–901.
  • Dixit V, Hariparsad N, Desai P, et al. (2007). In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities. Biopharm Drug Dispos 28:257–62.
  • Faber MS, Jetter A, Fuhr U. (2005). Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol 97:125–34.
  • Guo H, Liu AH, Li L, et al. (2007). Simultaneous determination of 12 major constituents in Forsythia suspensa by high performance liquid chromatography-DAD method. J Pharm Biomed Anal 43:1000–6.
  • Han YL, Li D, Ren B, et al. (2012). Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol 139:104–9.
  • Jian YY, Jin LW. (2009). Chemical constituents of Forsythia suspensa and pharmacology study. Journal of Huaihai Medicine 27:349–50.
  • Kaminsky LS, Zhang ZY. (1997). Human P450 metabolism of warfarin. Pharmacol Ther 73:67–74.
  • Kupiec T, Raj V. (2005). Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 29:755–8.
  • Lahoz A, Donato MT, Picazo L, et al. (2008). Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry. Drug Metab Lett 2:205–9.
  • Lei JL, Li YT, Nie HS, et al. (2012). Determination of phillyrin in fructus Forsythiae from different habitats by HPLC. Chin Arch Tradit Chin Med 30:202–4.
  • Li H, Wu J, Zhang Z, et al. (2011). Forsythoside a inhibits the avian infectious bronchitis virus in cell culture. Phytother Res 25:338–42.
  • Liu J. (2008). Experimental study on the immunological function and anti-stress of phillyrin. J Shaanxi Inst Educ 24:59–61.
  • Mathijssen RH, Verweij J, de Bruijn P, et al. (2002). Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94:1247–9.
  • Meng XL, Li JP, Li D, et al. (2010). Studies on the chemical constituents and pharmacological activities of Forsythia suspensa. China Pharmacy 21:4117–18.
  • Nebert DW, Russell DW. (2002). Clinical importance of the cytochromes P450. Lancet Oncol 360:1155–62.
  • Otani K, Aoshima T. (2000). Pharmacogenetics of classical and new antipsychotic drugs. Ther Drug Monit 22:118–21.
  • Otten JN, Hingorani GP, Hartley DP, et al. (2011). An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS. Drug Metab Lett 5:17–24.
  • Ozaki Y, Rui J, Tang Y, et al. (1997). Antiinflammatory effect of Forsythia Suspensa Vahl and its active principle. Biol Pharm Bull 23:861–4.
  • Prieto JM, Recio MR, Manez S, et al. (2003). Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol 55:1275–82.
  • Pharmacopoeia Commission of PRC. (2015). Pharmacopoeia of the People's Republic of China. Beijing: Chemical Industry Press.
  • Rettie AE, Jones JP. (2005). Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annu Rev Pharmacol Toxicol 45:477–94.
  • Saxena A, Parijat Tripathi K, Roy S, et al. (2008). Pharmacovigilance: effects of herbal components on human drugs interactions involving Cytochrome P450. Bioinformation 3:198–204.
  • Teh LK, Bertilsson L. (2012). Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metab Pharmacokinet 27:55–67.
  • Wang LL, Shi YZ, Wang X, et al. (2012). Progress of anti-influenza virus by Chinese herbs. Northwest Pharma J 27:600–4.
  • Xiao P, Zhou HH. (2008). Advance in cytochrome P450 1A2. 33:456–60.
  • Yan SL, Hu JP, Xu YX, et al. (2003). Simultaneous evaluation of activity of hepatic CYP450 following administration of Fisch Fructus Forsythiae by Cocktail probe drugs. Chin Pharm J 38:761–3.
  • Yang TH, Huang L, Zheng XH. (2013). The content determination of phillyrin and forsythoside A of Forsythia suspense leaves by different origins. Clin Med Eng 3:288–9.
  • Yeung JH, Chan SL, Or PM. (2006). Polysaccharide peptides from COV-1s train of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo. Food Chem Toxicol 44:1414–23.
  • Yu AM, Idle JR, Gonzalez FJ. (2004). Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab Rev 36:243–77.
  • Zhang LW, Liu J, Yang P. (2003). Antioxidant effect of the Chinese herb Forsythia suspensa extract. Food Sci 24:122–5.
  • Zhang X. (2016). Observation of curative effect by Tanreqing injection combined with azithromycin in the treatment of adult mycoplasmal pneumonia. Chin J Mod Drug Appl 10:13–14.
  • Zhou S, Yung Chan S, Cher Goh B, et al. (2005). Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279–304.
  • Zhou SF, Zhou ZW, Li CG, et al. (2007). Identification of drugs that interact with herbs in drug development. Drug Discov Today 12:664–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.